The agency considered that the decision aims to protect public health in the face of the indiscriminate use of medicines
The National Health Surveillance Agency (Anvisa) decided on Wednesday 16th that Pharmacies from all over the country should keep the prescription in the sale of slimming pens so calledAs Ozempic, Saxenda AND Wegovy. The drugs, originally suitable for patients with type 2 diabetes, have also been used for weight loss, often without adequate medical follow -up.
Before the decision, it was sufficient to present the revenue at the time of purchase. With the new rule, it will be necessary to provide one of the routes of the prescription at the time of the acquisition. According to Anvisa, the decision aims to increase control over the use of these drugs and protect public health in the face of the “irrational consumption” of drugs.
To be accepted in pharmacies, revenues should be valid for a maximum of 90 days and contain two ways. In addition, the factories must register the document in the National Controlled Product Management System (SNGPC). The decision is valid 60 days after the official publication, scheduled for the next few days.
Receive the main news directly on WhatsApp! Sign up for the Earth channel
Anvisa stressed that an increase in the number of adverse events relating to the indiscriminate use of products for weight loss has occurred. Inadequate use can cause nausea, abdominal distension, constipation and diarrhea to the aggravation of psychological and food disorders.
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
